A 24-week, Randomized, Open-label, 2-arm Study to Compare the Safety, Efficacy and Tolerability of Invirase Tablets With Ritonavir Versus Kaletra Tablets in HIV 1 Infected Adults on a Kaletra Based Regimen With 2 Nucleosides/Nucleotides.

Trial Profile

A 24-week, Randomized, Open-label, 2-arm Study to Compare the Safety, Efficacy and Tolerability of Invirase Tablets With Ritonavir Versus Kaletra Tablets in HIV 1 Infected Adults on a Kaletra Based Regimen With 2 Nucleosides/Nucleotides.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Jul 2011

At a glance

  • Drugs Lopinavir/ritonavir; Ritonavir; Saquinavir
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Acronyms LoCKIT
  • Most Recent Events

    • 15 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Jul 2011 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
    • 26 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top